Comparison of clinical characteristics of wild-type SARS-CoV-2 and Omicron

Detalhes bibliográficos
Autor(a) principal: Kirca,Füsun
Data de Publicação: 2022
Outros Autores: Aydoğan,Sibel, Gözalan,Ayşegül, Kayipmaz,Afşin Emre, Özdemir,Fatma Ayça Edis, Tekçe,Yasemin Tezer, Beşer,İpek Omay, Gün,Pınar, Ökten,Rıza Sarper, Dinç,Bedia
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista da Associação Médica Brasileira (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022001001476
Resumo: SUMMARY OBJECTIVE: This study aimed to investigate the effect of mutations by comparing wild-type SARS-CoV-2 and Omicron regarding clinical features in patients with COVID-19. It also aimed to assess whether SARS-CoV-2 cycle threshold value could predict COVID-19 severity. METHODS: A total of 960 wild-type and 411 Omicron variant patients with positive results in SARS-CoV-2 real-time reverse transcriptase polymerase chain reaction test from oropharyngeal and/or nasopharyngeal samples during their hospital admissions were included in this retrospective study. The reference symptoms of the patients were obtained from the hospital database. The correlation between chest computed tomography findings and the “cycle threshold” of patients with wild-type SARS-CoV-2 was assessed. RESULTS: Cough, fever, shortness of breath, loss of taste and smell, and diarrhea were found to be statistically significantly higher (p=0.001; 0.001; 0.001; 0.001; and 0.006; respectively) in the wild-type cohort, while in the Omicron cohort, sore throat and headache were found to be statistically significantly higher (p=0.001 and 0.003, respectively). An inverse relationship was found between chest computed tomography findings and viral load. CONCLUSION: This study revealed that the Omicron variant tended to infect predominantly the upper respiratory tract and showed decreased lung infectivity, and the disease progressed with a milder clinical course. Therefore, the study showed that the tropism of the virus was changed and the viral phenotype was affected. It was also found that SARS-CoV-2 viral load did not predict COVID-19 severity in patients with wild-type SARS-CoV-2.
id AMB-1_520f159b531dc0e8e6dcc601e029da11
oai_identifier_str oai:scielo:S0104-42302022001001476
network_acronym_str AMB-1
network_name_str Revista da Associação Médica Brasileira (Online)
repository_id_str
spelling Comparison of clinical characteristics of wild-type SARS-CoV-2 and OmicronCOVID-19SARS-CoV-2 variantsCoronavirusViral loadSUMMARY OBJECTIVE: This study aimed to investigate the effect of mutations by comparing wild-type SARS-CoV-2 and Omicron regarding clinical features in patients with COVID-19. It also aimed to assess whether SARS-CoV-2 cycle threshold value could predict COVID-19 severity. METHODS: A total of 960 wild-type and 411 Omicron variant patients with positive results in SARS-CoV-2 real-time reverse transcriptase polymerase chain reaction test from oropharyngeal and/or nasopharyngeal samples during their hospital admissions were included in this retrospective study. The reference symptoms of the patients were obtained from the hospital database. The correlation between chest computed tomography findings and the “cycle threshold” of patients with wild-type SARS-CoV-2 was assessed. RESULTS: Cough, fever, shortness of breath, loss of taste and smell, and diarrhea were found to be statistically significantly higher (p=0.001; 0.001; 0.001; 0.001; and 0.006; respectively) in the wild-type cohort, while in the Omicron cohort, sore throat and headache were found to be statistically significantly higher (p=0.001 and 0.003, respectively). An inverse relationship was found between chest computed tomography findings and viral load. CONCLUSION: This study revealed that the Omicron variant tended to infect predominantly the upper respiratory tract and showed decreased lung infectivity, and the disease progressed with a milder clinical course. Therefore, the study showed that the tropism of the virus was changed and the viral phenotype was affected. It was also found that SARS-CoV-2 viral load did not predict COVID-19 severity in patients with wild-type SARS-CoV-2.Associação Médica Brasileira2022-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022001001476Revista da Associação Médica Brasileira v.68 n.10 2022reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/1806-9282.20220880info:eu-repo/semantics/openAccessKirca,FüsunAydoğan,SibelGözalan,AyşegülKayipmaz,Afşin EmreÖzdemir,Fatma Ayça EdisTekçe,Yasemin TezerBeşer,İpek OmayGün,PınarÖkten,Rıza SarperDinç,Bediaeng2022-11-11T00:00:00Zoai:scielo:S0104-42302022001001476Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2022-11-11T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false
dc.title.none.fl_str_mv Comparison of clinical characteristics of wild-type SARS-CoV-2 and Omicron
title Comparison of clinical characteristics of wild-type SARS-CoV-2 and Omicron
spellingShingle Comparison of clinical characteristics of wild-type SARS-CoV-2 and Omicron
Kirca,Füsun
COVID-19
SARS-CoV-2 variants
Coronavirus
Viral load
title_short Comparison of clinical characteristics of wild-type SARS-CoV-2 and Omicron
title_full Comparison of clinical characteristics of wild-type SARS-CoV-2 and Omicron
title_fullStr Comparison of clinical characteristics of wild-type SARS-CoV-2 and Omicron
title_full_unstemmed Comparison of clinical characteristics of wild-type SARS-CoV-2 and Omicron
title_sort Comparison of clinical characteristics of wild-type SARS-CoV-2 and Omicron
author Kirca,Füsun
author_facet Kirca,Füsun
Aydoğan,Sibel
Gözalan,Ayşegül
Kayipmaz,Afşin Emre
Özdemir,Fatma Ayça Edis
Tekçe,Yasemin Tezer
Beşer,İpek Omay
Gün,Pınar
Ökten,Rıza Sarper
Dinç,Bedia
author_role author
author2 Aydoğan,Sibel
Gözalan,Ayşegül
Kayipmaz,Afşin Emre
Özdemir,Fatma Ayça Edis
Tekçe,Yasemin Tezer
Beşer,İpek Omay
Gün,Pınar
Ökten,Rıza Sarper
Dinç,Bedia
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Kirca,Füsun
Aydoğan,Sibel
Gözalan,Ayşegül
Kayipmaz,Afşin Emre
Özdemir,Fatma Ayça Edis
Tekçe,Yasemin Tezer
Beşer,İpek Omay
Gün,Pınar
Ökten,Rıza Sarper
Dinç,Bedia
dc.subject.por.fl_str_mv COVID-19
SARS-CoV-2 variants
Coronavirus
Viral load
topic COVID-19
SARS-CoV-2 variants
Coronavirus
Viral load
description SUMMARY OBJECTIVE: This study aimed to investigate the effect of mutations by comparing wild-type SARS-CoV-2 and Omicron regarding clinical features in patients with COVID-19. It also aimed to assess whether SARS-CoV-2 cycle threshold value could predict COVID-19 severity. METHODS: A total of 960 wild-type and 411 Omicron variant patients with positive results in SARS-CoV-2 real-time reverse transcriptase polymerase chain reaction test from oropharyngeal and/or nasopharyngeal samples during their hospital admissions were included in this retrospective study. The reference symptoms of the patients were obtained from the hospital database. The correlation between chest computed tomography findings and the “cycle threshold” of patients with wild-type SARS-CoV-2 was assessed. RESULTS: Cough, fever, shortness of breath, loss of taste and smell, and diarrhea were found to be statistically significantly higher (p=0.001; 0.001; 0.001; 0.001; and 0.006; respectively) in the wild-type cohort, while in the Omicron cohort, sore throat and headache were found to be statistically significantly higher (p=0.001 and 0.003, respectively). An inverse relationship was found between chest computed tomography findings and viral load. CONCLUSION: This study revealed that the Omicron variant tended to infect predominantly the upper respiratory tract and showed decreased lung infectivity, and the disease progressed with a milder clinical course. Therefore, the study showed that the tropism of the virus was changed and the viral phenotype was affected. It was also found that SARS-CoV-2 viral load did not predict COVID-19 severity in patients with wild-type SARS-CoV-2.
publishDate 2022
dc.date.none.fl_str_mv 2022-10-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022001001476
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022001001476
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1806-9282.20220880
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Médica Brasileira
publisher.none.fl_str_mv Associação Médica Brasileira
dc.source.none.fl_str_mv Revista da Associação Médica Brasileira v.68 n.10 2022
reponame:Revista da Associação Médica Brasileira (Online)
instname:Associação Médica Brasileira (AMB)
instacron:AMB
instname_str Associação Médica Brasileira (AMB)
instacron_str AMB
institution AMB
reponame_str Revista da Associação Médica Brasileira (Online)
collection Revista da Associação Médica Brasileira (Online)
repository.name.fl_str_mv Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)
repository.mail.fl_str_mv ||ramb@amb.org.br
_version_ 1754212838191136768